AnandRathi

Bafna Pharmaceuticals Ltd Fundamental Analysis

Last Updated Date: 08 Oct 2026
₹416.70
+8.15 (+1.99%)

Bafna Pharmaceuticals Ltd (Bafna Pharma.) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹986 crore.

Bafna Pharmaceuticals Ltd Overview

Market cap₹986 Crs
Volume7,129
Prev. Close₹408.55
Year range₹95.00 - ₹416.70
ISININE878I01022

Bafna Pharmaceuticals Ltd Fundamentals

ROCE(TTM)10.63%
P/E Ratio (TTM)126.66
P/B Ratio10.25
Debt to Equity0.39
ROE11.54%
EPS (TTM)3.29
Dividend Yield0.00%
Book Value40.64
Profit Margin5.46%
Operating Margin3.70%

Bafna Pharmaceuticals Ltd Historical Performance

1 Month Return35.05%
6 Month Return245.67%
3 Year Return366.89%
3 Month Return100.67%
1 Year Return153.70%
5 Year Return225.17%

Bafna Pharmaceuticals Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research